Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Symptom Management
Patient-Reported Physical Symptoms More Likely to Be Addressed by Oncologists Than Depression or Anxiety
By
Meg Barbor, MPH
Symptom Management
February 2019, Vol 9, No 2
Read More ›
Targeted Intervention Reduces Opioid Use by Nearly 50% After Urologic Oncology Surgery
By
Meg Barbor, MPH
Symptom Management
December 2018, Vol 8, No 12
Patients can be successfully managed with minimal opioid medication after urologic oncology surgery, said Kerri Stevenson, MN, NP-C, RNFA, CWOCN, Lead Advanced Practice Provider – Interventional Radiology, Stanford Health Care, CA, at the 2018 ASCO Quality Care Symposium.
Read More ›
Managing Anxiety in Patients with Advanced Cancer
By
Meg Barbor, MPH
Symptom Management
,
Supportive Care
,
Symptom Management
November 2018, Vol 8, No 11
Anxiety is a common symptom in patients with advanced cancer, and is associated with reduced quality of life, increased symptom burden, poor medication adherence, and suboptimal treatment decisions at the end of life.
Read More ›
High Rates of Sleep Deficiency and Cancer-Related Fatigue Across Diagnoses
By
Meg Barbor, MPH
Symptom Management
October 2018, Vol 8, No 10
Among patients with cancer, sleep deficiency and cancer-related fatigue rank highest in prevalence and severity during all treatment phases, regardless of cancer type or stage.
Read More ›
Omega-3 Fatty Acids Significantly Reduced Pain in Obese Patients with Breast Cancer
By
Meg Barbor, MPH
Symptom Management
October 2018, Vol 8, No 10
Omega-3 fatty acids significantly reduced aromatase inhibitor (AI)-induced joint pain in obese women with breast cancer, according to a new retrospective analysis of the SWOG S0927 study, a 24-week, randomized, controlled clinical trial that compared omega-3 fatty acids and placebo in patients with AI-related arthralgia.
Read More ›
Cognitive Behavioral Therapy More Effective Than Acupuncture for Mild Insomnia in Cancer Survivors
By
Meg Barbor, MPH
Symptom Management
October 2018, Vol 8, No 10
Read More ›
Cannabis for Symptom Management in Cancer: Do You Know What Your Patients Are Using?
By
Meg Barbor, MPH
Medicinal Cannabis
,
Symptom Management
September 2018, Vol 8, No 9
Patients with cancer are increasingly using cannabinoids (the chemical component of cannabis) to treat many symptoms, and a minority of them even take cannabis as a treatment for the cancer itself. Recent surveys have revealed that up to 25% of patients with cancer take some form of cannabis, but oncologists and other medical providers are often unaware that their patients are using medical (or recreational) cannabis.
Read More ›
Managing Cancer-Related Fatigue and Insomnia in Patients and Caregivers
By
Meg Barbor, MPH
Symptom Management
September 2018, Vol 8, No 9
Cancer-related fatigue and insomnia frequently co-occur among patients with cancer, and emerging data have demonstrated that caregivers of patients with cancer also have a high symptom burden, with elevated rates of depression, sleep disturbance, and fatigue
Read More ›
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Outs: What Are the Implications for Patients and Practices?
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
New Policies Regarding Intravenous Iron Replacement Are Creating Conundrum for Providers and Payers
By
Dawn Holcombe, MBA, FACMPE, ACHE
3.
2023 Spotlight: Amgen
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes